End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13,379 ARS | +3.17% | +2.46% | +43.35% |
06-14 | Amgen Gets FDA Approval to Treat Aggressive Leukemia Type with Blincyto | DJ |
06-14 | Amgen Says FDA Approves Blincyto to Treat Type of Blood Cancer | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
AMGEN INC. | Other Pharmaceuticals | +3.17% | +2.46% | +43.35% | +244.82% | +22,167.42% | 164B | - | - | - |
- Stock Market
- Equities
- AMGN Stock
- AMGN Stock
- Charts Amgen Inc.
- Relative Strength Chart